Popular searches: AAPL TSLA NVDA MSFT GOOGL

ASTH Stock Price Prediction 2026

Astrana Health Inc. Common Stock

$22.74
+$0.33 (+1.47%)

AI-powered price predictions based on fundamental analysis and growth projections

Last Updated: January 30, 2026
🎯
AI TRADING RECOMMENDATION
Evaluate position
Key Signals:
  • • Volume showing distribution (CMF: -0.1323)
  • • Recent pattern: Doji - Indecision pattern
MACD: Bearish | Volume: Distribution
Fair Value Estimate
+29.8% Undervalued
Fair Value: $29.51 (Current: $22.74)

Based on PEG ratio analysis, this stock appears undervalued at current levels. The fair value estimate suggests 29.8% upside potential.

PEG Ratio
0.37
Attractive
Current P/E
23.04
Fair P/E
29.90
Earnings Growth
62.2%
📉

Volume Trend: Distribution

Selling Pressure Present - Distribution pattern observed

Chaikin Money Flow (CMF): -0.132
Money Flow Index (MFI): 35.5

Negative CMF indicates money flowing out of the stock. Exercise caution as this may signal distribution.

Options Analysis: 1-Year Target Strategy

Score: 0/100

Analysis comparing options pricing vs AI growth projections. This helps identify if options are cheap (buy calls) or expensive (sell premium).

STRONG SELL SIGNAL - Massively overpriced, excellent premium selling opportunity
Growth Target (1Y)
$23.06
+2.5% upside
Best Strike Found
$25.00
Exp: May 15, 2026, midnight
Call Premium
$2.60
11.6% of stock price
Breakeven Price
$27.60
⚠ Above target
Implied Probability
44.0%
Market's confidence
Value Score
-100.0
Overpriced
💰
STRONG SELL
Options are overpriced - Sell premium opportunity
Seller's Advantage:
Premium Collected
$2.60
Profit if Target Hits
$2.60
ROI if Target Hits
+100.0%
Why This Works: Buyers lose 100.0% even if target hits. Premium is overpriced for 2.5% move.
Suggested Strategies: Covered Call (safest) Naked Call (risky) Credit Spread (defined risk)
Open Interest: 5 | Volume: 1
Data as of: May 22, 2025
How to Use This Analysis: Value Score shows profitability if the 1-year growth target is reached. Positive score = profitable for buyers. Negative score = profit opportunity for premium sellers (covered calls, credit spreads).
Price Targets by Timeframe
AI-based growth projections (not Wall Street analyst targets)
Timeframe Target Price Potential Return
30 Days $22.67 -0.3%
90 Days $22.51 -1.0%
6 Months $22.28 -2.0%
1 Year $21.83 -4.0%
2 Years EXTENDED $21.26 -6.5%
3 Years EXTENDED $20.71 -8.9%

More ASTH Analysis

Why is ASTH Moving? Buy or Sell ASTH? ASTH Full Analysis ASTH Trendline Analysis
ASTH Price Prediction Trendline

Scenario Analysis (1-Year Outlook)

Bull Case
30% Probability
$27.29 (+20.0%)

Best case scenario if strong fundamentals and market conditions align

Base Case
50% Probability
$21.83 (+-4.0%)

Expected scenario based on current growth trajectory

Bear Case
20% Probability
$15.28 (-32.8%)

Downside scenario if market headwinds or disappointing results

Technical Indicators

RSI (14)
37.3
Neutral
MACD Signal
Bearish
Trend
Downtrend
Money Flow (CMF)
-0.13

Key Fundamentals

P/E Ratio
115.79
Forward P/E
23.04
P/S Ratio (TTM)
0.38x
Very Undervalued
Revenue Growth (QoQ)
1.0%
Earnings Growth (QoQ)
-1.0%
Market Cap
$1,103M
Analyst Target
$36.89
52-Week High
$23.28
52-Week Low
$22.23
Investment Disclaimer: These price predictions are generated using AI models and historical data. They are not financial advice and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Buy or Sell Analysis Trendline Analysis Investment Advisor Options Advisor Options Chain & Analysis